The rarity of hepatoblastoma (HB) and childhood hepatocellular carcinoma (HCC) necessitates international collaboration between countries and even continents, to give the possibility of conducting successful clinical trials in such rare tumors.
We invite you as colleagues, to participate with us in our program of research and contribute patients to our clinical trials.
CONDITIONS OF COLLABORATION
To become a participating member we require:
- Full contact details (Form of Participation to be filled in for each trial)
- Details of how many patients you may expect to enter each year
- Agreement to register all relevant patients to our trials
- Agreement to submit timely clinical data and to respond to individually requested data queries.
To participate in the trials complete this questionnaire and send into SIOPEL Data Centre on:
Fax: + 48 58 76 40 361